Naji H. Gehchan
Chief Medical & Development OfficerDr. Naji H. Gehchan, M.D., MBA, is Chief Medical & Development Officer of Kyverna Therapeutics, Inc. from January 22, 2025. Dr. Gehchan has many years of U.S. and international experience across multiple therapeutic areas, including immunology, as both an accomplished pharmaceutical executive and a physician. Dr. Gehchan joined Kyverna in January 2025 from Eli Lilly and Company, where he served as the Head of Clinical Development for imlunestrant, a novel breast cancer treatment. In this role, he advanced this complex development program from Phase 1 to global submissions, laying the groundwork for a successful launch. Dr. Gehchan spent more years at Lilly, holding key senior leadership positions, including Associate Vice President of Sales for the U.S. Diabetes Team and Chief Marketing Officer/Business Unit Senior Director for Lilly France, Belgium and Netherlands, where he successfully led the launch of Lilly's immunology medicines. Prior to this, Dr. Gehchan worked as a Business Unit Manager, European Medical Affairs Lead and Clinical Research Physician. He began his career as a medical doctor at Hôtel-Dieu de France in Beirut and served as a First Responder, Team Leader and Member of the Medical Committee at the Lebanese Red Cross. Dr. Gehchan holds a Doctor of Medicine and Masters in Biological Science from Saint Joseph University of Beirut, a Specialized Master of Healthcare Management and Pharmaceutical Marketing from ESCP Business School and a Master of Business Administration from MIT Sloan.
Positions
- Company NameKyverna Therapeutics, Inc.Stock CodeKYTXPositionChief Medical & Development Officer
